Todd W. Miller

Also affiliated with Medical College of Wisconsin, Dartmouth Psychiatric Research Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Tumour, whole‐blood, plasma and tissue concentrations of metformin in lung cancer patients”.

Tumour, whole‐blood, plasma and tissue concentrations of metformin in lung cancer patients

British Journal of Clinical Pharmacology(2022)10.1111/bcp.15546

N/A

0.542DataRank · unranked

9 citations

Darcy B. Pooler, Dylan B. Ness, Kayla A. Fay, Steven Tau, Eugene Demidenko +4 more

Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0112

N/A

0.523DataRank · unranked

8 citations

Peter A. Kaufman, Karthik V. Giridhar, Jonathan D. Marotti, Mary D. Chamberlin, Bradley A. Arrick +7 more

Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on Fulvestrant

The Oncologist(2021)10.1002/onco.13733

N/A

0.467DataRank · unranked

8 citations

Kevin Shee, Bianca A. Romo, Jonathan D. Marotti, Alexei F. Kisselev, Lionel D. Lewis +2 more

Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple‐negative breast cancer

International Journal of Cancer(2024)10.1002/ijc.35274

N/A

0.315DataRank · unranked

6 citations

Lucas A. Salas, Jonathan D. Marotti, Nicole P. Jenkins, Chao Cheng, Todd W. Miller +3 more

Quantitative proteomics analysis of triple-negative breast cancers

npj Precision Oncology(2025)10.1038/s41698-025-00907-8

N/A

0.305DataRank · unranked

5 citations

Jonathan D. Marotti, Youdinghuan Chen, Barbara Karakyriakou, Roberto Salgado, Brock C. Christensen +3 more

Estrogen therapy induces receptor-dependent DNA damage enhanced by PARP inhibition in ER+ breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.16.532956

N/A

0.189DataRank · unranked

2 citations

Gary N. Schwartz, Steven Tau, Amanda Jiang, Sarah R. Hosford, Abigail E. Goen +11 more

Alteration of DNMT1/DNMT3A by eribulin elicits global DNA methylation changes with potential therapeutic implications for triple-negative breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.06.09.544426

N/A

0DataRank · unranked

2 citations

Min Kyung Lee, Kristen E. Muller, Todd W. Miller, Diwakar R. Pattabiraman, Brock C. Christensen +1 more

Data from A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer

(2023)10.1158/0008-5472.c.6503028.v1

N/A

0DataRank · unranked

0 citations

Todd W. Miller, Justin M. Balko, María G. Kuba, Violeta Sánchez, R. Adam Smith +9 more

Data from Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells

(2023)10.1158/1078-0432.c.6517720

N/A

0DataRank · unranked

0 citations

James T. Forbes, Chirayu Shah, Shelby K. Wyatt, H. Charles Manning, Maria G. Olivares +9 more

Data from Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells

(2023)10.1158/1078-0432.c.6517720.v1

N/A

0DataRank · unranked

0 citations

James T. Forbes, Chirayu Shah, Shelby K. Wyatt, H. Charles Manning, Maria G. Olivares +9 more

Pharmacological induction of chromatin remodeling drives chemosensitization in triple-negative breast cancer

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101504

N/A

0DataRank · unranked

17 citations

Gadisti A. Mohamed, Mohammed Ashick Mohamed Saleem, Nevena B. Ognjenovic, Hanxu Lu, Fred Kolling +9 more

TRIM33 Is a Co-Regulator of Estrogen Receptor Alpha

Cancers(2024)10.3390/cancers16050845

N/A

0DataRank · unranked

4 citations

Barbara Karakyriakou, Lauren Cressey, Brooke L. Brauer, Huijuan Yang, Alexa Warren +4 more

Endocrine persistence in ER+ breast cancer is accompanied by metabolic vulnerability in oxidative phosphorylation

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.26.615177

N/A

0DataRank · unranked

3 citations

Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti, Alyssa M. Roberts, Melissa M. Carmichael +11 more

Oxidative Phosphorylation Is a Metabolic Vulnerability of Endocrine Therapy–Tolerant Persister Cells in ER+ Breast Cancer

Cancer Research(2025)10.1158/0008-5472.can-24-1204

N/A

0DataRank · unranked

17 citations

Mary D. Chamberlin, Huijuan Yang, Jonathan D. Marotti, Patricia C. Muskus, Alyssa M. Roberts +12 more

Combined Radiation and Endocrine Therapies Elicit Benefit in ER+ Breast Cancer

Cancers(2025)10.3390/cancers17121921

N/A

0DataRank · unranked

1 citations

Steven Tau, Austin M. Sloop, Tianyuan Dai, Alyssa M. Roberts, Patricia C. Muskus +8 more

Reply to: “Comments on the paper ‘Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple‐negative breast cancer’ by Y. Chen et al.”

International Journal of Cancer(2025)10.1002/ijc.35434

N/A

0DataRank · unranked

0 citations

Lucas A. Salas, Jonathan D. Marotti, Nicole P. Jenkins, Chao Cheng, Todd W. Miller +3 more

AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0269

N/A

0DataRank · unranked

86 citations

Jason D. Wells, Nicole A. Traphagen, Charlotte F. McCleery, Jennifer Fields, Kevin Shee +10 more

Endocrine therapy induces oxidative stress in ER+ breast cancer that sensitizes persister cells to ferroptosis

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.18.665614

N/A

0DataRank · unranked

0 citations

Malone Friedman, Alyssa Roberts, Lauren R. Ferridge, Sierra A. Kleist, Lauren Cressey +4 more

Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3685

N/A

0DataRank · unranked

60 citations

Mellissa J. Nixon, Paula I. González-Ericsson, Riley E. Bergman, Mark A. Pilkinton, Wyatt J. McDonnell +21 more

AMPK activation by metformin promotes survival of dormant ER+ breast cancer cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.21.914382

N/A

0DataRank · unranked

4 citations

Jason D. Wells, Nicole A. Traphagen, Charlotte F. McCleery, Jennifer Fields, Kevin Shee +9 more

MP17-03 MICRORNA LET-7F-5P IS A NOVEL BIOMARKER OF RECURRENCE AND A POTENTIAL THERAPEUTIC OPPORTUNITY IN NON-MUSCLE INVASIVE BLADDER CANCER

The Journal of Urology(2020)10.1097/ju.0000000000000842.03

N/A

0DataRank · unranked

0 citations

Carmen J. Marsit, Alan R. Schned, Jason R. Pettus, David A. Armstrong, MARGARET R. KARAGAS +4 more

Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0488

N/A

0DataRank · unranked

19 citations

Gary N. Schwartz, Steven Tau, Alyssa M. Roberts, Amanda Jiang, Sarah R. Hosford +12 more

Pharmacological Induction of mesenchymal-epithelial transition chemosensitizes breast cancer cells and prevents metastatic progression

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.19.537586

N/A

0DataRank · unranked

5 citations

Gadisti A. Mohamed, Mohammed Ashick, Mohamed Ashick Mohamed Saleem, Nevena B. Ognjenovic, Hanxu Lu +10 more